Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (159)	4/13/1999 8:52:00 AM
From: LLCF	Read Replies (2) \| Respond to of 52153

Anyone find anything a tad twisted here? "Wall Street doesn't reward companies for good clinical data," said Larry Feinberg, a partner with hedge-fund Oracle Partners. "They only reward companies for sales and earnings." "Obviously, you're going to miss a lot of the upside," by investing later, he said. But since sales forecasts often go unmet, he noted, the better approach is to wait and see. His fund has holdings in two of the big boys - Amgen and Biogen. DAK